Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7243 results

Sort By:

Engaging Diverse and Underserved Communities in Cancer Awareness Training and Education

Study ID: NCT05761782
Start Date: 2023-03-07
End Date: 2025-03-07
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1500

Intervention / Treatment

Education

Sponsor

University of California, Davis

Source: clinicaltrials.gov

Share:
Add to list

DASH INtervention to INvestigate the Gut

Study ID: NCT04538482
Start Date: 2022-03-07
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

112

Intervention / Treatment

DASH Diet

standard American diet

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Source: clinicaltrials.gov

Share:
Add to list

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

Study ID: NCT03128866
Start Date: 2017-05-19
End Date: 2026-05-31
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

80

Intervention / Treatment

Hemipelvectomy

Tranexamic Acid

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

Study ID: NCT05056857
Start Date: 2021-10-01
End Date: 2026-10-31
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

290

Intervention / Treatment

Biospecimen Collection

Electronic Health Record Review

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Natural History Study of Parathyroid Disorders

Study ID: NCT04969926
Start Date: 2021-11-30
End Date: 2031-01-22
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

3000

Intervention / Treatment
Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma

Study ID: NCT06297226
Start Date: 2024-03-21
End Date: 2032-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

175

Intervention / Treatment

Arlocabtagene Autoleucel (BMS-986393)

Sponsor

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

Source: clinicaltrials.gov

Share:
Add to list

Effects of Simvastatin on Uterine Leiomyoma Size

Study ID: NCT03400826
Start Date: 2018-08-20
End Date: 2026-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

Simvastatin 40mg

Placebo 40 mg

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Study ID: NCT04239157
Start Date: 2020-08-25
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

76

Intervention / Treatment

Kankinumab

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Trial of 225Ac-DOTATATE (RYZ101) in Subjects with ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.

Study ID: NCT06590857
Start Date: 2024-07-19
End Date: 2033-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

124

Intervention / Treatment

Ryz101

Sponsor

RayzeBio, Inc.

Source: clinicaltrials.gov

Share:
Add to list

High Intensity Focused Ultrasound in Prostate Cancer

Study ID: NCT06402357
Start Date: 2025-05-14
End Date: 2029-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Focal One high intensity focused ultrasound device

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list